Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Akira Hiratate"'
Autor:
Akira Hiratate, Makoto Hamada, Lisa Okumura-Kitajima, Hiroko Koretsune, Takumi Naruse, Masato Takahashi, Hiroki Takano, Hiromitsu Kajiyama, Tsuyoshi Shibata, Hiroyuki Kakinuma, Noriko Takayama, Tetsuo Takayama, Sota Kato, Miyoko Yashiro
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 28:1725-1730
Prolyl hydroxylase domain-containing protein (PHD) inhibitors are useful as orally administered agents for the treatment of renal anemia. Based on the common structures of known PHD inhibitors, we found novel PHD inhibitor 1 with a 2-[(4-hydroxy-6-ox
Publikováno v:
Journal of Pesticide Science. 26:366-370
前報に続き, アルトラクトン, イソアルトラクトン, 5-ヒドロキシゴニオタラミンの両鏡像体の合成を行った. トリ-O-アセチル-D-グルカールから得られたアセタールに必要な側鎖を延長後,
Publikováno v:
Journal of Pesticide Science. 26:361-365
抗腫瘍活性物質アルトラクトン類の合成研究を行った. 2,3-O-シクロヘキシリデン-D-グリセルアルデヒドを出発物質として, 新たに3か所の不斉点を導入する経路を採用し, (-)-ent-アルトラク
Autor:
Daisuke Yamamoto, Akira Hiratate, Tomomichi Chonan, Miyoko Yashiro, Daisuke Wakasugi, Fusayo Io, Hiroko Koretsune, Hiroaki Tanaka, Ayumi Ohoka-Sugita, Takahiro Oi
Publikováno v:
Bioorganicmedicinal chemistry. 19(5)
Novel (4-piperidinyl)-piperazine derivatives were synthesized and evaluated as ACC1/2 non-selective inhibitors. Optimization of the substituents on the nitrogen of the piperidine ring led to the identification of the fluorine substituted tert-butoxyc
Autor:
Daisuke Yamamoto, Akira Hiratate, Hiroaki Tanaka, Tomomichi Chonan, Miyoko Yashiro, Hiroko Koretsune, Daisuke Wakasugi, Ayumi Ohoka-Sugita, Fusayo Io, Takahiro Oi
Publikováno v:
Bioorganicmedicinal chemistry letters. 20(13)
Acetyl-CoA carboxylases (ACCs), the rate limiting enzymes in de novo lipid synthesis, play important roles in modulating energy metabolism. The inhibition of ACC has demonstrated promising therapeutic potential for treating obesity and type 2 diabete
Autor:
Daisuke Wakasugi, Takahiro Oi, Miyoko Yashiro, Hiroaki Tanaka, Ayumi Ohoka-Sugita, Tomomichi Chonan, Akira Hiratate, Fusayo Io, Hiroko Koretsune, Daisuke Yamamoto
Publikováno v:
Bioorganicmedicinal chemistry letters. 19(23)
Acetyl-CoA carboxylases (ACCs), the rate limiting enzymes in de novo lipid synthesis, play important roles in modulating energy metabolism. The inhibition of ACC has demonstrated promising therapeutic potential for treating obesity and type 2 diabete
Autor:
Akira Hiratate, Yuji Takaoka, Hidetaka Saito, Koji Yamamoto, Masato Takahashi, Masako Saito-Hori, Eiji Munetomo, Hiroshi Fukushima, Kiyokazu Kitano
Publikováno v:
ChemInform. 40
Dipeptidyl peptidase IV (DPP-IV) inhibitors have attracted attention as potential drugs for use in the treatment of type 2 diabetes because they prevent the degradation of glucagon-like peptide-1 (GLP-1) and extend its duration of action. We previous
Autor:
Koji Yamamoto, Hidetaka Saito, Yuji Takaoka, Kiyokazu Kitano, Hiroshi Fukushima, Masato Takahashi, Eiji Munetomo, Masako Saito-Hori, Akira Hiratate
Publikováno v:
Chemicalpharmaceutical bulletin. 56(8)
Dipeptidyl peptidase IV (DPP-IV) inhibitors have attracted attention as potential drugs for use in the treatment of type 2 diabetes because they prevent the degradation of glucagon-like peptide-1 (GLP-1) and extend its duration of action. We previous
Autor:
Masato Takahashi, Koji Yamamoto, Eiji Munetomo, Akira Hiratate, Ayako Mikami, Hidetaka Saito, Yuji Takaoka, Akio Suzuki, Kiyokazu Kitano, Sumi Chonan, Masako Saito-Hori, Hiroshi Fukushima
Publikováno v:
Bioorganicmedicinal chemistry. 16(7)
Dipeptidyl peptidase IV (DPP-IV) inhibitors are promising antidiabetic drugs, and several drugs are in the developmental stage. We previously reported that the introduction of fluorine to the 4-position of 2-cyanopyrrolidine enhanced the DPP-IV inhib
Autor:
Kiyokazu Kitano, Eiji Munetomo, Koji Yamamoto, Yuji Takaoka, Hidetaka Saito, Hiroshi Fukushima, Akira Hiratate, Masako Saito, Masato Takahashi
Publikováno v:
Bioorganicmedicinal chemistry. 12(23)
Dipeptidyl peptidase IV (DPP-IV) inhibitors have attracted attention as potential drugs for use in the treatment of type 2 diabetes because they prevent degradation of glucagon-like peptide-1 (GLP-1) and extend its duration of action. A series of 2-c